NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/15/2026 15:25
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization24.02 mln
Float2.26 mln
Earnings Date07/30/2026
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.14
Very low leverage
ROE
-158
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
NextCure is a clinical-stage biotech company founded in 2015 and based in Beltsville, Maryland, focused on developing new treatments for cancer and other serious diseases. Its pipeline includes several experimental therapies targeting tumor cells, immune system pathways, and conditions such as Alzheimer's disease, osteoarthritis, and leukemia. Key programs include antibody-drug conjugates and fusion proteins designed to help the immune system fight disease more effectively.
